BACKGROUND:Adults with type 2 diabetes mellitus often have limitations in mobility that increase with age. An intensive lifestyle intervention that produces weight loss and improves fitness could slow the loss of mobility in such patients. METHODS: We randomly assigned 5145 overweight or obese adults between the ages of 45 and 74 years with type 2 diabetes to either anintensive lifestyle intervention or a diabetes support-and-education program; 5016 participants contributed data. We used hidden Markov models to characterize disability states and mixed-effects ordinal logistic regression to estimate the probability of functional decline. The primary outcome was self-reported limitation in mobility, with annual assessments for 4 years. RESULTS: At year 4, among 2514 adults in the lifestyle-intervention group, 517 (20.6%) had severe disability and 969 (38.5%) had good mobility; the numbers among 2502 participants in the support group were 656 (26.2%) and 798 (31.9%), respectively. The lifestyle-intervention group had a relative reduction of 48% in the risk of loss of mobility, as compared with the support group (odds ratio, 0.52; 95% confidence interval, 0.44 to 0.63; P<0.001). Both weight loss and improved fitness (as assessed on treadmill testing) were significant mediators of this effect (P<0.001 for both variables). Adverse events that were related to the lifestyle intervention included a slightly higher frequency of musculoskeletal symptoms at year 1. CONCLUSIONS:Weight loss and improved fitness slowed the decline in mobility in overweight adults with type 2 diabetes. (Funded by the Department of Health and Human Services and others; ClinicalTrials.gov number, NCT00017953.).
RCT Entities:
BACKGROUND: Adults with type 2 diabetes mellitus often have limitations in mobility that increase with age. An intensive lifestyle intervention that produces weight loss and improves fitness could slow the loss of mobility in such patients. METHODS: We randomly assigned 5145 overweight or obese adults between the ages of 45 and 74 years with type 2 diabetes to either an intensive lifestyle intervention or a diabetes support-and-education program; 5016 participants contributed data. We used hidden Markov models to characterize disability states and mixed-effects ordinal logistic regression to estimate the probability of functional decline. The primary outcome was self-reported limitation in mobility, with annual assessments for 4 years. RESULTS: At year 4, among 2514 adults in the lifestyle-intervention group, 517 (20.6%) had severe disability and 969 (38.5%) had good mobility; the numbers among 2502 participants in the support group were 656 (26.2%) and 798 (31.9%), respectively. The lifestyle-intervention group had a relative reduction of 48% in the risk of loss of mobility, as compared with the support group (odds ratio, 0.52; 95% confidence interval, 0.44 to 0.63; P<0.001). Both weight loss and improved fitness (as assessed on treadmill testing) were significant mediators of this effect (P<0.001 for both variables). Adverse events that were related to the lifestyle intervention included a slightly higher frequency of musculoskeletal symptoms at year 1. CONCLUSIONS:Weight loss and improved fitness slowed the decline in mobility in overweight adults with type 2 diabetes. (Funded by the Department of Health and Human Services and others; ClinicalTrials.gov number, NCT00017953.).
Authors: E W Gregg; G L Beckles; D F Williamson; S G Leveille; J A Langlois; M M Engelgau; K M Narayan Journal: Diabetes Care Date: 2000-09 Impact factor: 19.112
Authors: Annemarie Koster; Kushang V Patel; Marjolein Visser; Jacques Th M van Eijk; Alka M Kanaya; Nathalie de Rekeneire; Anne B Newman; Frances A Tylavsky; Stephen B Kritchevsky; Tamara B Harris Journal: J Am Geriatr Soc Date: 2008-02-14 Impact factor: 5.562
Authors: Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson Journal: Arthritis Rheum Date: 2004-05
Authors: Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski Journal: Control Clin Trials Date: 2003-10
Authors: Paul M Ribisl; Wei Lang; Sarah A Jaramillo; John M Jakicic; Kerry J Stewart; Judy Bahnson; Renee Bright; Jeff F Curtis; Richard S Crow; Judith E Soberman Journal: Diabetes Care Date: 2007-07-20 Impact factor: 19.112
Authors: Rachel A Murphy; Ilse Reinders; Thomas C Register; Hilsa N Ayonayon; Anne B Newman; Suzanne Satterfield; Bret H Goodpaster; Eleanor M Simonsick; Stephen B Kritchevsky; Tamara B Harris Journal: Am J Clin Nutr Date: 2014-02-12 Impact factor: 7.045
Authors: Judith G Regensteiner; Timothy A Bauer; Amy G Huebschmann; Leah Herlache; Howard D Weinberger; Eugene E Wolfel; Jane E B Reusch Journal: Med Sci Sports Exerc Date: 2015-01 Impact factor: 5.411
Authors: Edward W Gregg; Ji Lin; Barbara Bardenheier; Haiying Chen; W Jack Rejeski; Xiaohui Zhuo; Andrea L Hergenroeder; Stephen B Kritchevsky; Anne L Peters; Lynne E Wagenknecht; Edward H Ip; Mark A Espeland Journal: Diabetes Care Date: 2018-03-15 Impact factor: 19.112